Skip to main content
NCBI home page
British Medical Journal (Clinical Research Ed.) logoLink to British Medical Journal (Clinical Research Ed.)
. 1985 Oct 26;291(6503):1150–1152. doi: 10.1136/bmj.291.6503.1150

Calcium channel blocking agents and the heart.

J Kenny
PMCID: PMC1417868  PMID: 3931832

Full text

PDF
1150

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Antman E., Muller J., Goldberg S., MacAlpin R., Rubenfire M., Tabatznik B., Liang C. S., Heupler F., Achuff S., Reichek N. Nifedipine therapy for coronary-artery spasm. Experience in 127 patients. N Engl J Med. 1980 Jun 5;302(23):1269–1273. doi: 10.1056/NEJM198006053022301. [DOI] [PubMed] [Google Scholar]
  2. Belhassen B., Horowitz L. N. Use of intravenous verapamil for ventricular tachycardia. Am J Cardiol. 1984 Nov 1;54(8):1131–1133. doi: 10.1016/s0002-9149(84)80158-7. [DOI] [PubMed] [Google Scholar]
  3. Benaim M. E. Asystole after verapamil. Br Med J. 1972 Apr 15;2(5806):169–170. doi: 10.1136/bmj.2.5806.169-b. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Bertel O., Conen D., Radü E. W., Müller J., Lang C., Dubach U. C. Nifedipine in hypertensive emergencies. Br Med J (Clin Res Ed) 1983 Jan 1;286(6358):19–21. doi: 10.1136/bmj.286.6358.19. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Betriu A., Chaitman B. R., Bourassa M. G., Brévers G., Scholl J. M., Bruneau P., Gagné P., Chabot M. Beneficial effect of intravenous diltiazem in the acute management of paroxysmal supraventricular tachyarrhythmias. Circulation. 1983 Jan;67(1):88–94. doi: 10.1161/01.cir.67.1.88. [DOI] [PubMed] [Google Scholar]
  6. Bhatnagar S. K., Amin M. M., Al-Yusuf A. R. Diabetogenic effects of nifedipine. Br Med J (Clin Res Ed) 1984 Jul 7;289(6436):19–19. doi: 10.1136/bmj.289.6436.19. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Braunwald E. Mechanism of action of calcium-channel-blocking agents. N Engl J Med. 1982 Dec 23;307(26):1618–1627. doi: 10.1056/NEJM198212233072605. [DOI] [PubMed] [Google Scholar]
  8. Breckenridge A. The third drug in hypertension. Br Med J (Clin Res Ed) 1984 Oct 6;289(6449):859–860. doi: 10.1136/bmj.289.6449.859. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Deanfield J., Wright C., Fox K. Treatment of angina pectoris with nifedipine: importance of dose titration. Br Med J (Clin Res Ed) 1983 May 7;286(6376):1467–1470. doi: 10.1136/bmj.286.6376.1467. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Gerstenblith G., Ouyang P., Achuff S. C., Bulkley B. H., Becker L. C., Mellits E. D., Baughman K. L., Weiss J. L., Flaherty J. T., Kallman C. H. Nifedipine in unstable angina: a double-blind, randomized trial. N Engl J Med. 1982 Apr 15;306(15):885–889. doi: 10.1056/NEJM198204153061501. [DOI] [PubMed] [Google Scholar]
  11. Goodwin J. F. The frontiers of cardiomyopathy. Br Heart J. 1982 Jul;48(1):1–18. doi: 10.1136/hrt.48.1.1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Gould B. A., Mann S., Kieso H., Subramanian V. B., Raftery E. B. The 24-hour ambulatory blood pressure profile with verapamil. Circulation. 1982 Jan;65(1):22–27. doi: 10.1161/01.cir.65.1.22. [DOI] [PubMed] [Google Scholar]
  13. Gray H. H., Poston L., Hilton P. J., Smith S. J., Markandu N. D., MacGregor G. A. Reversal by verapamil of defect in sodium transport in leucocytes in essential hypertension. Br Med J (Clin Res Ed) 1984 Mar 3;288(6418):673–675. doi: 10.1136/bmj.288.6418.673. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Henry P. D. Comparative pharmacology of calcium antagonists: nifedipine, verapamil and diltiazem. Am J Cardiol. 1980 Dec 1;46(6):1047–1058. doi: 10.1016/0002-9149(80)90366-5. [DOI] [PubMed] [Google Scholar]
  15. Hossack K. F., Bruce R. A. Improved exercise performance in persons with stable angina pectoris receiving diltiazem. Am J Cardiol. 1981 Jan;47(1):95–101. doi: 10.1016/0002-9149(81)90296-4. [DOI] [PubMed] [Google Scholar]
  16. Hossack K. F. Conduction abnormalities due to diltiazem. N Engl J Med. 1982 Oct 7;307(15):953–954. doi: 10.1056/nejm198210073071516. [DOI] [PubMed] [Google Scholar]
  17. Hung J., Lamb I. H., Connolly S. J., Jutzy K. R., Goris M. L., Schroeder J. S. The effect of diltiazem and propranolol, alone and in combination, on exercise performance and left ventricular function in patients with stable effort angina: a double-blind, randomized, and placebo-controlled study. Circulation. 1983 Sep;68(3):560–567. doi: 10.1161/01.cir.68.3.560. [DOI] [PubMed] [Google Scholar]
  18. Inouye I. K., Massie B. M., Benowitz N., Simpson P., Loge D. Antihypertensive therapy with diltiazem and comparison with hydrochlorothiazide. Am J Cardiol. 1984 Jun 1;53(11):1588–1592. doi: 10.1016/0002-9149(84)90584-8. [DOI] [PubMed] [Google Scholar]
  19. Kendall M. J., Horton R. C. Are calcium antagonists cardioprotective? J R Coll Physicians Lond. 1985 Apr;19(2):85–89. [PMC free article] [PubMed] [Google Scholar]
  20. Kerin N. Z., Blevins R. D., Frumin H., Faitel K., Rubenfire M. Intravenous and oral loading versus oral loading alone with amiodarone for chronic refractory ventricular arrhythmias. Am J Cardiol. 1985 Jan 1;55(1):89–91. doi: 10.1016/0002-9149(85)90305-4. [DOI] [PubMed] [Google Scholar]
  21. Lynch P., Dargie H., Krikler S., Krikler D. Objective assessment of antianginal treatment: a double-blind comparison of propranolol, nifedipine, and their combination. Br Med J. 1980 Jul 19;281(6234):184–187. doi: 10.1136/bmj.281.6234.184. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Mehta J., Pepine C. J., Day M., Guerrero J. R., Conti C. R. Short-term efficacy of oral verapamil in rest angina. A double-blind placebo controlled trial in CCU patients. Am J Med. 1981 Dec;71(6):977–982. doi: 10.1016/0002-9343(81)90323-5. [DOI] [PubMed] [Google Scholar]
  23. Mueller H. S., Chahine R. A. Interim report of multicenter double-blind, placebo-controlled studies of nifedipine in chronic stable angina. Am J Med. 1981 Oct;71(4):645–657. doi: 10.1016/0002-9343(81)90229-1. [DOI] [PubMed] [Google Scholar]
  24. Murphy M. B., Scriven A. J., Dollery C. T. Role of nifedipine in treatment of hypertension. Br Med J (Clin Res Ed) 1983 Jul 23;287(6387):257–259. doi: 10.1136/bmj.287.6387.257. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. O'Hara M. J., Khurmi N. S., Bowles M. J., Subramanian V. B., Doré C. J., Raftery E. B. Comparison of diltiazem at two dose levels with propranolol for treatment of stable angina pectoris. Am J Cardiol. 1984 Sep 1;54(6):477–481. doi: 10.1016/0002-9149(84)90234-0. [DOI] [PubMed] [Google Scholar]
  26. Oesterle S. N., Schroeder J. S. Calcium-entry blockade, beta-adrenergic blockade and the reflex control of circulation. Circulation. 1982 Apr;65(4):669–670. doi: 10.1161/01.cir.65.4.669. [DOI] [PubMed] [Google Scholar]
  27. Oliva P. B. Unstable rest angina with ST-segment depression. Pathophysiologic considerations and therapeutic implications. Ann Intern Med. 1984 Mar;100(3):424–440. doi: 10.7326/0003-4819-100-3-424. [DOI] [PubMed] [Google Scholar]
  28. Opie L. H. Calcium antagonists. Mechanisms, therapeutic indications and reservations: a review. Q J Med. 1984 Winter;53(209):1–16. [PubMed] [Google Scholar]
  29. Parker J. O., Fung H. L., Ruggirello D., Stone J. A. Tolerance to isosorbide dinitrate: rate of development and reversal. Circulation. 1983 Nov;68(5):1074–1080. doi: 10.1161/01.cir.68.5.1074. [DOI] [PubMed] [Google Scholar]
  30. Petru M. A., Crawford M. H., Kennedy G. T., Amon K. W., O'Rourke R. A. Long-term efficacy of high-dose diltiazem for chronic stable angina pectoris: 16-month serial studies with placebo controls. Am Heart J. 1985 Jan;109(1):99–103. doi: 10.1016/0002-8703(85)90422-3. [DOI] [PubMed] [Google Scholar]
  31. Robson R. H., Vishwanath M. C. Nifedipine and beta-blockade as a cause of cardiac failure. Br Med J (Clin Res Ed) 1982 Jan 9;284(6309):104–104. doi: 10.1136/bmj.284.6309.104. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Schroeder J. S., Lamb I. H., Bristow M. R., Ginsburg R., Hung J., McAuley B. J. Prevention of cardiovascular events in variant angina by long-term diltiazem therapy. J Am Coll Cardiol. 1983 Jun;1(6):1507–1511. doi: 10.1016/s0735-1097(83)80056-4. [DOI] [PubMed] [Google Scholar]
  33. Schwartz J. B., Keefe D., Kates R. E., Kirsten E., Harrison D. C. Acute and chronic pharmacodynamic interaction of verapamil and digoxin in atrial fibrillation. Circulation. 1982 Jun;65(6):1163–1170. doi: 10.1161/01.cir.65.6.1163. [DOI] [PubMed] [Google Scholar]
  34. Subramanian B., Bowles M. J., Davies A. B., Raftery E. B. Combined therapy with verapamil and propranolol in chronic stable angina. Am J Cardiol. 1982 Jan;49(1):125–132. doi: 10.1016/0002-9149(82)90286-7. [DOI] [PubMed] [Google Scholar]
  35. Subramanian V. B., Bowles M. J., Khurmi N. S., Davies A. B., Raftery E. B. Randomized double-blind comparison of verapamil and nifedipine in chronic stable angina. Am J Cardiol. 1982 Oct;50(4):696–703. doi: 10.1016/0002-9149(82)91221-8. [DOI] [PubMed] [Google Scholar]
  36. Subramanian V. B., Lahiri A., Paramasivan R., Raftery E. B. Verapamil in chronic stable angina. A controlled study with computerized multistage treadmill exercise. Lancet. 1980 Apr 19;1(8173):841–844. doi: 10.1016/s0140-6736(80)91351-3. [DOI] [PubMed] [Google Scholar]
  37. Talano J. V., Tommaso C. Slow channel calcium antagonists in the treatment of supraventricular tachycardia. Prog Cardiovasc Dis. 1982 Sep-Oct;25(2):141–156. doi: 10.1016/0033-0620(82)90025-1. [DOI] [PubMed] [Google Scholar]
  38. Walsh R. A., Badke F. R., O'Rourke R. A. Differential effects of systemic and intracoronary calcium channel blocking agents on global and regional left ventricular function in conscious dogs. Am Heart J. 1981 Sep;102(3 Pt 1):341–350. doi: 10.1016/0002-8703(81)90307-0. [DOI] [PubMed] [Google Scholar]
  39. Winniford M. D., Fulton K. L., Corbett J. R., Croft C. H., Hillis L. D. Propranolol-verapamil versus propranolol-nifedipine in severe angina pectoris of effort: a randomized, double-blind, crossover study. Am J Cardiol. 1985 Feb 1;55(4):281–285. doi: 10.1016/0002-9149(85)90361-3. [DOI] [PubMed] [Google Scholar]
  40. Winniford M. D., Fulton K. L., Hillis L. D. Long-term therapy of paroxysmal supraventricular tachycardia: a randomized, double-blind comparison of digoxin, propranolol and verapamil. Am J Cardiol. 1984 Nov 1;54(8):1138–1139. doi: 10.1016/s0002-9149(84)80162-9. [DOI] [PubMed] [Google Scholar]
  41. Zelis R. Calcium-blocker therapy for unstable angina pectoris. N Engl J Med. 1982 Apr 15;306(15):926–928. doi: 10.1056/NEJM198204153061508. [DOI] [PubMed] [Google Scholar]

Articles from British Medical Journal (Clinical research ed.) are provided here courtesy of BMJ Publishing Group

RESOURCES